Comparative physicochemical properties and cytotoxicity of polyphosphoester ionomers with bisphosphonates

Journal of Biomaterials Science, Polymer Edition

Volumn 24, Issue 7, 2013, Pages 882-895

  Iwasaki, Yasuhiko ^a   Katayama, Koichi ^a   Yoshida, Munehiro ^a   Yamamoto, Masaya ^b   Tabata, Yasuhiko ^b  

^a KANSAI UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

biocompatibility; bisphosphonate; hydroxyapatite; osteoblast; polyphosphoester ionomer

Indexed keywords

ADSORPTION; BIOCOMPATIBILITY; HYDROXYAPATITE; IONIZATION; MINERAL RESOURCES; OSTEOBLASTS; SALTS;

BISPHOSPHONATES; CELL COMPATIBILITY; HYDROXYAPATITE (HAP); MICRO-PARTICLES; ORGANOCATALYSTS; PHYSICOCHEMICAL PROPERTY; POLYPHOSPHOESTERS; SELECTIVE ADSORPTION;

IONOMERS;

ALENDRONIC ACID; BIOMATERIAL; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; ETIDRONIC ACID; HYDROXYAPATITE; IBANDRONIC ACID; PAMIDRONIC ACID; POLY(2 BENZOXY 2 OXO 1,3,2 DIOXAPHOSPHOLANE CO 2 ETHOXY 2 OXO 1,3,2 DIOXAPHOSPHOLANE); POLYMER; RISEDRONIC ACID; SODIUM; UNCLASSIFIED DRUG; ZOLEDRONIC ACID; MICROSPHERE; PHOSPHATE;

ADSORPTION; ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; MINERALIZATION; MOUSE; NONHUMAN; OSTEOBLAST; PHYSICAL CHEMISTRY; POLYMERIZATION; PRIORITY JOURNAL; ZETA POTENTIAL; ANIMAL; CHEMISTRY; COMPARATIVE STUDY;

ADSORPTION; ANIMALS; DIPHOSPHONATES; DURAPATITE; MICE; MICROSPHERES; PHOSPHATES; PHYSICOCHEMICAL PROCESSES; POLYMERS;

EID: 84898761024     PISSN: 09205063     EISSN: 15685624     Source Type: Journal    
DOI: 10.1080/09205063.2012.710823     Document Type: Article

References (47)

1. Bartl R, Frisch B, von Tresckow E, Bartl C. Bisphosphonates. In: Bartl R, Frisch B, von Tresckow E, Bartl C, editors. Bisphosphonates in medical practice. actions, side effects, indications, strategies. Berlin: Springer-Verlag; 2007. p. 33-70.
2. Russell RG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, Kavanagh KL, Triffitt JT, Lundy MW, Phipps RJ, Barnett BL, Coxon FP, Rogers MJ, Watts NB, Ebetino FH. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Annals of the New York Academy of Sciences. 2007;1117:209-57.
3. Dominguez LJ, Di Bella G, Belvedere M, Barbagallo M. Physiology of the aging bone and mechanisms of action of bisphosphonates. Biogerontology. 2011;12:397-408.
4. Yoneda T, Michigami T, Yi B, Williams PJ, Niewolna M, Hiraga T. Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma. Cancer. 2000;88:2979-88.
5. Vatassery GT, Armstrong WD, Singer L. Determination of hydroxyl content of calcified tissue mineral. Calcified Tissue Research. 1970;5:183-8.
6. Low SA, Kopecek J. Targeting polymer therapeutics to bone. Advanced Drug Delivery Reviews. DOI: 10.1016/j.addr.2012.01.012.
7. Greish K, Fang J, Inutsuka T, Nagamitsu A, Maeda H. Macromolecular therapeutics: advantages and prospects with special emphasis on solid tumour targeting. Clinical Pharmacokinetics. 2003;42:1089-105.
8. Fox M, Szoka F, Frechet JMJ. Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Accounts of Chemical Research. 2009;42:1141-51.
9. Jain RH. Transport of molecules in the tumor interstitium: a review. Cancer Research. 1987;47:3039-51.
10. Kaluzynski K, Libisowskiand J, Penczek S. A new class of synthetic polyelectrolytes. Acidic polyesters of phosphoric acid, (poly(hydroxylakylene phosphates). Macromolecules. 1976;9:365-7.
11. Gitsov I, Johnson FE. Synthesis and hydrolytic stability of poly(oxyethylene-H-phosphonate)s. Journal of Polymer Science Part A: Polymer Chemistry. 2008;46:4130-9.
12. Iwasaki Y, Kawakita T, Yusa S. Thermoresponsive polyphosphoesters bearing enzyme-cleavable side chains. Chemistry Letters. 2009;38:1054-5.
13. 3 crystallization. Journal of Polymer Science Part A: Polymer Chemistry. 2005;43:650-7.
14. Wan AC, Mao HQ, Wang S, Phua SH, Lee GP, Pan J, Lu S, Wang J, Leong KW. Poly(phosphoester) ionomers as tissue-engineering scaffolds. Journal of Biomedical Materials Research Part B: Applied Biomaterials.. 2004;70:91-102.
15. Edmundson RS. Oxidation of cyclic phosphorochloridites. Chemistry & Industry (London, United Kingdom). 1962:1828-9.
16. Iwasaki Y, Wachiralarpphaithoon C, Akiyoshi K. Novel thermoresponsive polymers having biodegradable phosphoester backbones. Macromolecules. 2007;40:8136-8.
17. Van Gelder JM, Breuer E, Ornoy A, Schlossman A, Patlas N, Golomb G. Anticalcification and antiresorption effects of bisacylphosphonates. Bone. 1995;16:511-20.
18. Franceschi RT, Iyer BS, Cui Y. Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. Journal of Bone and Mineral Research. 1994;9:843-54.
19. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. Journal of Bone and Mineral Research. 1999;14:893-903.
20. Zhao Z, Wang J, Mao HQ, Leong KW. Polyphosphoesters in drug and gene delivery. Advanced Drug Delivery Reviews. 2003;55:483-99.
21. Wang YC, Yuan YY, Du JZ, Yang XZ, Wang J. Recent progress in polyphosphoesters: from controlled synthesis to biomedical applications. Macromolecular Bioscience. 2009;9:1154-64.
22. Monge S, Canniccioni B, Graillot A, Robin JJ. Phosphorus-containing polymers: a great opportunity for the biomedical field. Biomacromolecules. 2011;12:1973-82.
23. Wachiralarpphaithoon C, Iwasaki Y, Akiyoshi K. Enzyme-degradable phosphorylcholine porous hydrogels cross-linked with polyphosphoesters for cell matrices. Biomaterials. 2007;28:984-93.
24. Penczek S, Klosinski P. Synthetic polyphosphates related to nucleic and teichoic acids. In: Penczek S, editor. Model of biopolymer by ring-opening polymerization. Boca Raton (FL): CRC Press; 1990. p. 291-378.
25. Pretula J, Kaluzynski K, Penczek S. Synthesis of poly (alkylene phosphates) with nitrogen-containing bases in the side chains. 1. Nitrogen- and carbon-substituted imidazoles. Macromolecules. 1986;19:1797-9.
26. Iwasaki Y, Yamaguchi E. Synthesis of well-defined thermoresponsive polyphosphoester macroinitiators using organocatalysts. Macromolecules. 2010;43:2664-6.
27. Libiszowski J, Kałużynski K, Penczek S. Polymerization of cyclic esters of phosphoric acid. VI. Poly(alkyl ethylene phosphates). Polymerization of 2-alkoxy-2-oxo-1,3,2-dioxaphospholans and structure of polymers. Journal of Polymer Science: Polymer Chemistry Edition. 1978;16:1275-83.
28. Baran J, Penczek S. Hydrolysis of polyesters of phosphoric acid. 1. Kinetics and the pH profile. Macromolecules. 1995;28:5167-76.
29. Masel RI. Adsorption II: adsorption isotherms. In: Masel RI, editor. Principles of adsorption and reaction on solid surfaces. New York (NY): Wiley Interscience; 1996. p. 235-353.
30. Hafez IT, Paraskeva CA, Klepetsanis PG, Koutsoukos PG. Study of polyacrylic acid adsorption on the interface of hydroxyapatite - electrolyte solutions. Global Nest Journal. 2010;12:270-8.
31. Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russell RG, Ebetino FH. Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone. 2006;38:617-27.
32. Cohen H, Solomon V, Alferiev IS, Breuer E, Ornoy A, Patlas N, Eidelman N, Hägele G, Golomb G. Bisphosphonates and tetracycline: experimental models for their evaluation in calcium-related disorders. Pharmaceutical Research. 1998;15:606-13.
33. Lin JH. Bisphosphonates: a review of their pharmacokinetic properties. Bone. 1996;18:75-85.
34. Vitha T, Kubícek V, Hermann P, Elst LV, Muller RN, Kolar ZI, Wolterbeek HT, Breeman WA, Lukes I, Peters JA. Lanthanide(III) complexes of bis(phosphonate) monoamide analogues of DOTA: bone-seeking agents for imaging and therapy. Journal of Medicinal Chemistry. 2008;51:677-83.
35. Mukherjee S, Huang C, Guerra F, Wang K, Oldfield E. Thermodynamics of bisphosphonates binding to human bone: a two-site model. Journal of American Chemical Society. 2009;131:8374-5.
36. Kowada T, Kikuta J, Kubo A, Ishii M, Maeda H, Mizukami S, Kikuchi K. In vivo fluorescence imaging of bone-resorbing osteoclasts. Journal of American Chemical Society. 2011;133:17772-6.
37. Francis MD, Martodam RR. Chemical, biochemical, and medicinal properties of the diphosphonates. In: Hildebrand RL, editor. The role of phosphonates in living systems. Boca Raton (FL): CRC Press; 1983. p. 55-96.
38. Price PA, Faus SA, Williamson MK. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arteriosclerosis, Thrombosis, and Vascular Biology. 2001;21:817-24.
39. Orriss IR, Key ML, Colston KW, Arnett TR. Inhibition of osteoblast function in vitro by aminobisphosphonates. Journal of Cellular Biochemistry. 2009;106:109-18.
40. Igarashi K, Hirafuji M, Adachi H, Shinoda H, Mitani H. Effects of bisphosphonates on alkaline phosphatase activity, mineralization, and prostaglandin E2 synthesis in the clonal osteoblast-like cell line MC3T3-E1. Prostaglandins, Leukotrienes and Essential Fatty Acids. 1997;56:121-5.
41. Itoh F, Aoyagi S, Furihata-Komatsu H, Aoki M, Kusama H, Kojima M, Kogo H. Clodronate stimulates osteoblast differentiation in ST2 and MC3T3-E1 cells and rat organ cultures. European Journal of Pharmacology. 2003;477:9-16.
42. Moon HJ, Yun YP, Han CW, Kim MS, Kim SE, Bae MS, Kim GT, Choi YS, Hwang EH, Lee JW, Lee JM, Lee CH, Kim DS, Kwon IK. Effect of heparin and alendronate coating on titanium surfaces on inhibition of osteoclast and enhancement of osteoblast function. Biochemical and Biophysical Research Communications. 2011;413:194-200.
43. Addison WN, McKee MD. Inositol hexakisphosphate inhibits mineralization of MC3T3-E1 osteoblast cultures. Bone. 2010;46:1100-7.
44. Yang XZ, Sun TM, Dou S, Wu J, Wang YC, Wang J. Block copolymer of polyphosphoester and poly(L-lactic acid) modified surface for enhancing osteoblast adhesion, proliferation, and function. Biomacromolecules. 2009;10:2213-20.
45. Bruzzaniti A, Baron R. Molecular regulation of osteoclast activity. Reviews in Endocrine & Metabolic Disorders. 2006;7:123-39.
46. Whitfield JF. How to grow bone to treat osteoporosis and mend fractures. Current Osteoporosis Reports. 2003;1:32.
47. Reinholz MM, Zinnen SP, Dueck AC, Dingli D, Reinholz GG, Jonart LA, Kitzmann KA, Bruzek AK, Negron V, Abdalla AK, Arendt BK, Croatt AJ, Sanchez-Perez L, Sebesta DP, Lönnberg H, Yoneda T, Nath KA, Jelinek DF, Russell SJ, Ingle JN, Spelsberg TC, Dixon HB, Karpeisky A, Lingle WL. A promising approach for treatment of tumor-induced bone diseases: utilizing bisphosphonate derivatives of nucleoside antimetabolites. Bone. 2010;47:12-22.